Integrated BioPharma, Inc. (INBP)
0.165
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
Integrated BioPharma Free Cash Flow (Quarterly) : -1.343M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.343M |
| March 31, 2026 | 0.517M |
| December 31, 2025 | 0.593M |
| September 30, 2025 | 1.128M |
| June 30, 2025 | 0.587M |
| March 31, 2025 | 0.50M |
| December 31, 2024 | 0.172M |
| September 30, 2024 | 0.601M |
| June 30, 2024 | -0.332M |
| March 31, 2024 | 1.298M |
| December 31, 2023 | -1.851M |
| September 30, 2023 | 1.275M |
| June 30, 2023 | -1.204M |
| March 31, 2023 | 1.454M |
| December 31, 2022 | -0.076M |
| September 30, 2022 | 0.942M |
| June 30, 2022 | 2.668M |
| March 31, 2022 | 0.532M |
| December 31, 2021 | -1.565M |
| September 30, 2021 | 1.97M |
| June 30, 2021 | 0.567M |
| March 31, 2021 | 1.141M |
| December 31, 2020 | -0.818M |
| September 30, 2020 | 1.865M |
| June 30, 2020 | -2.266M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.434M |
| December 31, 2019 | -0.67M |
| September 30, 2019 | 1.627M |
| June 30, 2019 | 0.563M |
| March 31, 2019 | 0.552M |
| December 31, 2018 | -1.776M |
| September 30, 2018 | 0.575M |
| June 30, 2018 | -0.206M |
| March 31, 2018 | 0.697M |
| December 31, 2017 | -1.067M |
| September 30, 2017 | 1.497M |
| June 30, 2017 | -0.835M |
| March 31, 2017 | 0.441M |
| December 31, 2016 | 1.031M |
| September 30, 2016 | -0.567M |
| June 30, 2016 | 0.154M |
| March 31, 2016 | 0.339M |
| December 31, 2015 | -1.591M |
| September 30, 2015 | 0.395M |
| June 30, 2015 | -0.165M |
| March 31, 2015 | 1.475M |
| December 31, 2014 | -0.995M |
| September 30, 2014 | -0.663M |
| June 30, 2014 | -0.287M |
| March 31, 2014 | 1.011M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Medifast, Inc. | 2.868M |
| BioForce Nanosciences Holdings, Inc. | -0.027M |
| Skinvisible, Inc. | 0.0022M |
| SkyTech Orion Global Corp. | -0.16M |
| Nevis Brands, Inc. | -- |